As of September 2026, 425 paid clinical trials are recruiting in Grand Rapids, Michigan. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Grand Rapids offers studies at sites including START Midwest for conditions such as Colorectal Cancer, Advanced Solid Tumors, Ovarian Cancer, Advanced Solid Tumor. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Researchers run research studies in Grand Rapids, MI at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| START Midwest | Colorectal Cancer, Solid Tumor, Advanced Solid Tumors | 62 |
| Corewell Health Grand Rapids Hospitals - Butterworth Hospital | Malignant Solid Neoplasm, Anatomic Stage II Breast Cancer AJCC v8, Lung Non-Small Cell Carcinoma | 59 |
| Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital | Malignant Solid Neoplasm, Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia | 50 |
| Corewell Health | Amblyopia, Ovarian Cancer, Acromioclavicular Joint | 40 |
| Trinity Health Grand Rapids Hospital | Malignant Solid Neoplasm, Advanced Lung Non-Small Cell Carcinoma, Intracranial Meningioma | 30 |
| Helen DeVos Children's Hospital | Cystic Fibrosis, Focal Segmental Glomerulosclerosis, ATRT Recurrent | 16 |
| BAMF Health | Colorectal Cancer, Prostate Cancer, Ovarian Cancer | 10 |
| Helen DeVos Children's Hospital at Spectrum Health | Muscular Atrophy, Spinal, Acral Lentiginous Melanoma, Anatomic Stage IV Breast Cancer AJCC v8 | 8 |
| START Midwest, LLC | Advanced Solid Tumors, Advanced Breast Cancer, Advanced NRAS-Mutant Melanoma | 8 |
| Spectrum Health at Butterworth Campus | Metastatic Malignant Neoplasm in the Brain, Acral Lentiginous Melanoma, Anatomic Stage IV Breast Cancer AJCC v8 | 8 |
| Cancer and Hematology Centers of Western Michigan | Diffuse Large B-cell Lymphoma (DLBCL), Metastatic Breast Cancer, Metastatic Colorectal Cancer | 8 |
| South Texas Accelerated Research Therapeutics (START) Midwest | Advanced Solid Tumors, Colorectal Cancer, Colorectal Carcinoma | 7 |
| The Cancer & Hematology Centers | Advanced Solid Tumor, Breast Cancer, Carcinoma, Non-Small-Cell Lung | 5 |
| Corewell Health West | Angina Pectoris, Atrial Fibrillation, Chest Pain | 5 |
| START - Midwest | Advanced Solid Tumors, Advanced or Metastatic Castration-Resistant Prostate Cancer (mCRPC), Advanced or Metastatic ER+ HER2- Breast Cancer (mBC) | 5 |
| Spectrum Health | Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML or ANLL), Autoimmune Diseases | 5 |
| The Cancer and Hematology Centers | B Cell Lymphoma, Chronic Lymphocytic Leukemia, Extra-Pancreatic Neuroendocrine Tumor (epNET) | 5 |
| Foundation for Vision Research | Geographic Atrophy, Macular Degeneration, Macular Telangiectasia Type 2 (MacTel) | 4 |
| GSK Investigational Site | Breast Neoplasms, Multiple Myeloma, Neoplasms | 4 |
| Cancer & Hematology Centers of Western Michigan | Bladder Carcinoma, Breast Cancer, Colon Adenocarcinoma | 4 |
| BAMF Health Inc. | Breast Neoplasms, Colorectal Neoplasms, Esophageal Neoplasms | 3 |
| Pediatric Ophthalmology, P.C. | Amblyopia | 3 |
| Spectrum Health Medical Group | Bladder Cancer, Cardiovascular Diseases, Connective Tissue Diseases | 3 |
| Cancer And Hematology Centers Of Western Michigan - Grand Rapids | Metastatic Pancreatic Ductal Adenocarcinoma, PDAC, Small Cell Lung Cancer | 3 |
| Cancer And Hematology Centers of Western Michigan PC | Colorectal Neoplasms, Multiple Myeloma | 2 |
Recruiting trials in Grand Rapids grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
There are approximately 425 recruiting clinical trials in Grand Rapids, Michigan listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Grand Rapids compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Grand Rapids include Colorectal Cancer (17), Advanced Solid Tumors (16), Ovarian Cancer (11), Advanced Solid Tumor (10), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Grand Rapids on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Grand Rapids include START Midwest, Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Grand Rapids are Cancer & tumors (228), Cardiovascular (20), Neurology & pain (11). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.